Taxotere Permanent Hair Loss Lawsuits Continue
Sanofi-Aventis is facing some 800 lawsuits as part of a federal MDL Taxotere Plaintiffs Allege Drug Makers Never Warned of Permanent Hair Loss. Sanofi-Aventis is facing some 800 lawsuits as part of a federal multidistrict litigation (MDL) in the U.S. District Court for the Eastern District of Louisiana. Plaintiffs allege that … [Read more...]
Pretrial Orders Issued in Taxotere Hair Loss MDL
The Taxotere permanent hair loss MDL is continuing to move forward  Pretrial Orders in Taxotere Hair Loss MDL. The Taxotere permanent hair loss multidistrict litigation (MDL) is continuing to move forward, as several pretrial orders have been issued. On Jan. 19, 2017, the court issued its 12th Pretrial Order requiring that … [Read more...]
Women Struggle with Permanent Hair Loss After Taxotere Chemotherapy
Taxotere (Docetaxel) Chemotherapy Drug May Lead to Permanent Hair Loss Taxotere Chemotherapy Drug Side Effects. Taxotere (Docetaxel) Chemotherapy Drug May Lead to Permanent Hair Loss. For some patients who have been treated with the chemotherapy drug Taxotere (docetaxel), the usual physical and emotional effects of … [Read more...]
Taxotere Permanent Hair Loss Devastates Patients
Taxotere alopecia (hair loss) has been permanent Taxotere (docetaxel) received U.S. Food and Drug Administration (FDA) approval in 1996. Sanofi, Aventis Pharma SA in France and Sanofi-Aventis US LLC in the United States promoted Taxotere as an effective chemotherapy medication for cancer patients. Taxotere was touted for … [Read more...]
Taxotere Permanent Alopecia
Taxotere is likelier to lead to permanent alopecia Chemotherapy Agent, Taxotere, Associated with Permanent Hair Loss. Taxotere (docetaxel) is a breast cancer medication marketed by Sanofi-Aventis and is often administered in collaboration with other cancer drugs. Since its approval by the U.S. Food and Drug Administration in … [Read more...]
Taxotere May Lead to Permanent Hair Loss
Cancer survivors who were prescribed Taxotere by their oncologist could suffer permanent hair loss. Hair loss, called Alopecia, is expected when taking a chemotherapy drug. However, a cancer victim’s hair typically regrows within three or four months after stopping the chemotherapy regimen. Survivors who took Taxotere could suffer a … [Read more...]
Woman Alleges Permanent Alopecia after Using Taxotere Chemotherapy Drug
Sanofi-Aventis is facing another lawsuit over its chemotherapy drug, Taxotere. A woman alleges that the company failed to warn about the risk of permanent alopecia, or hair loss, after taking Taxotere. She alleges that the company misled her and her oncologist about the risks of Taxotere and claims that she would have chosen a … [Read more...]
Lawsuits Filed when Permanent Chemotherapy Hair Loss is Linked to Taxotere
Breast cancer patients are usually familiar with the likely side effect of chemotherapy of hair loss. Most, however, expect that hair grows back once the chemotherapy is over. However, an increasing number of breast cancer patients are finding that this is not always the case after they have taken certain drugs. Sanofi Aventis, … [Read more...]
New Lawsuit Filed over Taxotere Alleges Permanent Hair Loss
Sanofi-Aventis is facing a new lawsuit filed over Taxotere, a chemotherapy drug used to treat breast cancer and other forms of cancer. The suit, filed on behalf of a Mississippi woman, alleges that the drug resulted in alopecia, or permanent hair loss. The suit focuses on the alleged lack of warning. The plaintiff started taking … [Read more...]
Sanofi Faces Another Lawsuit over Taxotere
Sanofi-Aventis faces another lawsuit alleging that its chemotherapy drug Taxotere led to permanent hair loss, or alopecia. The suit accuses the drug maker of failing to adequately warn about the risk of irreversible hair loss. The plaintiff is a California woman who was diagnosed with Stage II breast cancer in 2010. She underwent six … [Read more...]
Permanent Hair Loss Linked To Taxotere Breast Cancer Treatment
Hair Loss Linked To Taxotere. A number of women undergoing chemotherapy for breast cancer have recently come forward naming Taxotere (docetaxel) as a possible cause for their apparent permanent hair loss. Many have filed lawsuits against Taxotere’s manufacturer, Sanofi-Aventis. Patients are attracted to Taxotere as it is received … [Read more...]
Taxotere and the Risk of Alopecia
The U.S. Food and Drug Administration (FDA) approved Taxotere as a chemotherapy drug in 1996. Taxotere is manufactured by Sanofi-Aventis and is commonly used to treat breast cancer, as well as other cancers. Some patients taking Taxotere have reported experiencing permanent hair loss, or alopecia. In December 2015, the FDA warned … [Read more...]
Women Never Warned About Risk of Baldness with Taxotere
Sanofi failed to disclose this side effect. Taxotere is a Two Edge Sword. Taxotere is a chemotherapy drug that is commonly used to treat breast cancer. Studies show that the drug, which is manufactured by Sanofi-Aventis, is effective at extending patient survival. However, some patients have taken issue with a particular side … [Read more...]
Lawsuits Allege Patients were Never Warned of Permanent Baldness with Taxotere
Lawsuits are being filed over Taxotere, a chemotherapy drug manufactured by Sanofi-Aventis. Plaintiffs allege that they were never warned about the risk of permanent baldness when taking the drug, claiming they would have considered a different option if they were fully informed. Taxotere was approved by the U.S. Food and Drug … [Read more...]
